U.S. Markets closed
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • Dow 30

    34,584.88
    -166.44 (-0.48%)
     
  • Nasdaq

    15,043.97
    -137.96 (-0.91%)
     
  • Russell 2000

    2,236.87
    +3.96 (+0.18%)
     
  • Crude Oil

    71.96
    -0.65 (-0.90%)
     
  • Gold

    1,753.90
    -2.80 (-0.16%)
     
  • Silver

    22.42
    -0.33 (-1.44%)
     
  • EUR/USD

    1.1732
    -0.0040 (-0.3402%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • Vix

    20.81
    +2.12 (+11.34%)
     
  • GBP/USD

    1.3737
    -0.0059 (-0.4286%)
     
  • USD/JPY

    109.8950
    +0.1770 (+0.1613%)
     
  • BTC-USD

    48,153.59
    -560.79 (-1.15%)
     
  • CMC Crypto 200

    1,193.48
    -32.05 (-2.62%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • Nikkei 225

    30,500.05
    +176.71 (+0.58%)
     

Global Cardiovascular Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021

·14 min read

DUBLIN, Sept. 10, 2021 /PRNewswire/ -- Gain comprehensive access to over 850 cardiovascular partnering deal records from this report "Global Cardiovascular Partnering 2014-2021: Deal Trends, Players and Financials" that has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo
Research and Markets Logo

Global Cardiovascular Partnering 2014 to 2021 provides the full collection of Cardiovascular disease deals signed between the world's pharmaceutical and biotechnology companies since 2014.

  • Trends in Cardiovascular partnering deals

  • Financial deal terms for headline, upfront and royalty by stage of development

  • Cardiovascular partnering agreement structure

  • Cardiovascular partnering contract documents

  • Top Cardiovascular deals by value

  • Most active Cardiovascular dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Cardiovascular disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Cardiovascular deals.

The report presents financial deal terms values for Cardiovascular deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Cardiovascular dealmaking trends.

  • Chapter 1 provides an introduction to the report.

  • Chapter 2 provides an overview of the trends in Cardiovascular dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

  • Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

  • Chapter 4 provides a review of the leading Cardiovascular deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active Cardiovascular dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

  • Chapter 5 provides comprehensive access to Cardiovascular deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

  • Chapter 6 provides a comprehensive directory of all Cardiovascular partnering deals by specific Cardiovascular target announced since 2014. The chapter is organized by specific Cardiovascular therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Cardiovascular partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Cardiovascular partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Cardiovascular technologies and products.

Report Scope

The report is intended to provide the reader with an in-depth understanding and access to cardiovascular trends and structure of deals entered into by leading companies worldwide.

Global Cardiovascular Partnering 2014-2021: Deal trends, players and financials includes:

  • Trends in cardiovascular dealmaking in the biopharma industry since 2014

  • Analysis of cardiovascular deal structure

  • Access to headline, upfront, milestone and royalty data

  • Access to over 850 cardiovascular deal records

  • The leading cardiovascular deals by value since 2014

The report includes deals for the following indications: Abdominal aortic aneurysm, Angina, Arrhythmia, Atrial fibrillation, Long QT syndrome, Supraventricular Tachycardia, Ventricular fibrillation, Ventricular tachycardia, Atherosclerosis, Breathlessness, Cardiogenic shock, Cardiomyopathy (heart muscle disease), Chest pain, Congenital heart disease, Congestive heart failure, Coronary artery disease, Ductus arteriosus, Fatigue, Hypercholesterolemia, Hypertension, Intermittent claudication, Ischemic heart disease, Limb ischemia, Marfan's Syndrome, Myocardial Infarction, Oedema (excess fluid), Palpitations, Peripheral arterial disease, Thrombus (blood clot), Valvular heart disease, Aortic stenosis, Restenosis, Varicose veins, plus other cardiovascular indications.

In Global Cardiovascular Partnering 2014-2021: Deal trends, players and financials, the available deals are listed by:

  • Company A-Z

  • Headline value

  • Stage of development at signing

  • Deal component type

  • Specific therapy target

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Cardiovascular Partnering 2014-2021: Deal trends, players and financials report provides comprehensive access to available deals and contract documents for over 850 cardiovascular deals.

Analyzing actual contract agreements allows assessment of the following:

  • What are the precise rights granted or optioned?

  • What is actually granted by the agreement to the partner company?

  • What exclusivity is granted?

  • What is the payment structure for the deal?

  • How are the sales and payments audited?

  • What is the deal term?

  • How are the key terms of the agreement defined?

  • How are IPRs handled and owned?

  • Who is responsible for commercialization?

  • Who is responsible for development, supply, and manufacture?

  • How is confidentiality and publication managed?

  • How are disputes to be resolved?

  • Under what conditions can the deal be terminated?

  • What happens when there is a change of ownership?

  • What sublicensing and subcontracting provisions have been agreed?

  • Which boilerplate clauses does the company insist upon?

  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

  • Which jurisdiction does the company insist upon for agreement law?

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Cardiovascular dealmaking
2.1. Introduction
2.2. Cardiovascular partnering over the years
2.3. Cardiovascular partnering by deal type
2.4. Cardiovascular partnering by industry sector
2.5. Cardiovascular partnering by stage of development
2.6. Cardiovascular partnering by technology type
2.7. Cardiovascular partnering by therapeutic indication

Chapter 3 -Financial deal terms for Cardiovascular partnering
3.1. Introduction
3.2. Disclosed financials terms for Cardiovascular partnering
3.3. Cardiovascular partnering headline values
3.4. Cardiovascular deal upfront payments
3.5. Cardiovascular deal milestone payments
3.6. Cardiovascular royalty rates

Chapter 4 - Leading Cardiovascular deals and dealmakers
4.1. Introduction
4.2. Most active in Cardiovascular partnering
4.3. List of most active dealmakers in Cardiovascular
4.4. Top Cardiovascular deals by value

Chapter 5 - Cardiovascular contract document directory
5.1. Introduction
5.2. Cardiovascular partnering deals where contract document available

Chapter 6 - Cardiovascular dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Cardiovascular therapeutic target

Companies Mentioned

  • 1A Pharma

  • 3PrimeDx

  • 4D Molecular Therapeutics

  • 4D Pharma

  • 4SC Discovery

  • 36 Strategies General Trading

  • 480 Biomedical

  • A&D Medical

  • A&E Medical

  • A*STAR Agency for Science

  • Technology and Research

  • AADi

  • Abbott Laboratories

  • Abbott Vascular Devices

  • Abiomed

  • Ab Medica

  • Abyrx

  • Acasti Pharma

  • Accenture

  • Access Scientific

  • Access Vascular

  • ACEA Biosciences

  • Acino Pharma

  • Actelion

  • Actuated Cardio Engineering

  • Actuated Medical

  • Acutus Medical

  • ADAS 3D Medical

  • AddUp

  • Admedus

  • Admera Health

  • Advanced BioScience Laboratories

  • Advanced Cardiac Therapeutics

  • Advanced Catheter Therapies

  • Advanced Cooling Therapy

  • Adventus Ventures

  • Aegerion Pharmaceutical

  • Aerolase

  • Agena Bioscience

  • Agilent Technologies

  • Akcea Therapeutics

  • Akers Biosciences

  • Akrimax Pharmaceutical

  • Akums Drugs and Pharmaceuticals

  • Alibaba Health

  • AliveCor

  • Allegiance Health Foundation

  • Allergan

  • Alliance Medical

  • Alnylam Pharmaceuticals

  • Altrix Medical

  • Amarin

  • Amarna Therapeutics

  • American College of Emergency Physicians

  • American College of Physicians Foundation

  • American College of Surgeons

  • American Heart/Stroke Association

  • American Heart Association

  • AmeriCares

  • Amgen

  • Amneal Pharmaceuticals

  • AmorChem

  • Amos Gazit

  • AnaBios

  • Analog Devices

  • AnaMar

  • Angel Medical Systems

  • AnGes MG

  • Angiodynamics

  • Angion Biomedica

  • Angionetics

  • AngioSoma

  • ANI Pharmaceuticals

  • Antares Pharma

  • Antaros Medical

  • Anthem

  • Anthos Therapeutics

  • AOP Orphan Pharmaceuticals

  • APAC Scientific

  • Apicore

  • Aplagon

  • Apollo Hospitals Group

  • Apotex

  • Apple

  • Applied Medical

  • Aptahem

  • Aralez Pharmaceuticals

  • Ardelyx

  • Arena Pharmaceuticals

  • argenx

  • Argon Medical Devices

  • Armetheon

  • Aronora

  • Arrowhead Pharmaceuticals

  • Arteriae

  • Arterial Health International

  • Arterial Remodeling Technologies

  • Asahi Intecc

  • Ashland-Boyd County Health Department

  • ASKA Pharmaceuticals

  • Aspen Global

  • Aspen Holding

  • Aspire Health Science

  • Astellas Pharma

  • AstraZeneca

  • AstraZeneca HealthCare Foundation

  • Atelerix

  • Athersys

  • Atnahs Pharma

  • AutoGenomics

  • Autotelic

  • Aviir Diagnostics

  • Awamedica

  • Axiogenesis

  • Axol Bioscience

  • Aziyo Biologics

  • Baker IDI Heart and Diabetes Institute

  • Bardy Diagnostics

  • Baxter International

  • Bayer

  • Bayer Healthcare

  • Bay Labs

  • B Braun

  • Beijing Leadman Biochemistry

  • Beijing SL Pharma

  • Bellerophon Therapeutics

  • Bened Biomedical

  • Berg

  • Bertin Pharma

  • Bicycle Therapeutics

  • Bina Technologies

  • BioCardia

  • Bioengineering Laboratories

  • Biofourmis

  • BioHeart

  • BioLamina

  • BIOLIFE4D

  • BioLife Solutions

  • Biomerics

  • BioSig Technologies

  • Biostar

  • Biostar Pharmaceuticals

  • Biotectix

  • BioTelemetry

  • Biotricity

  • Biotronik

  • BioVectra

  • Bioventix

  • Biovic Sdn bhd

  • Bird Foundation

  • BlueRock Therapeutics

  • BodyTrace

  • Boehringer Ingelheim

  • Boryung Pharmaceutical

  • Boston Medical Center

  • Boston Pharmaceuticals

  • Boston Scientific

  • Breckenridge Pharmaceuticals

  • Brigham and Women's Hospital

  • Brigham Young University

  • Bristol-Myers Squibb

  • Broad Institute

  • Brooks Automation

  • Burgerhospital

  • Cadila Pharmaceuticals

  • Caladrius Biosciences

  • California Institute for Regenerative Medicine

  • California Institute of Technology

  • Canadian Institutes of Health Research

  • Capellabio

  • Capricor Therapeutics

  • Caprion Proteomics

  • Cardiac Insight

  • Cardiac Life

  • Cardinal Health

  • CardiNor

  • Cardio3 Biosciences Asia Holdings

  • CardioDx

  • CardioFocus

  • CardioLogic

  • Cardiome Pharma

  • Cardiorentis

  • Cardiovascular Cell Therapy Research Network

  • Cardiovascular Research Foundation

  • Cardiovascular Systems

  • Cardiowise

  • Cardium Therapeutics

  • Cardurion Pharmaceuticals

  • CareDx

  • CareLearning

  • Carestream Health

  • CareTaker Medical

  • Carmat

  • Carmel Pharma

  • Carrum Health

  • Casebia Therapeutics

  • Case Western Reserve University

  • CASI Pharmaceuticals

  • CAS Medical Systems

  • Catherine's Health Center

  • Catheter Precision

  • CDC Foundation

  • Cedars-Sinai Health System

  • Cedars-Sinai Medical Center

  • Celgene

  • Celladon

  • Cell and Gene Therapy Catapult

  • CELLINK

  • CellProThera

  • Cell Therapy

  • Celltrion

  • Cellular Logistics

  • CeloNova BioSciences

  • Celyad

  • Center for Biomarker Research in Medicine

  • Center for Connected Health

  • Centers for Medicare and Medicaid Services

  • Centron Diagnostics

  • Cevec Pharmaceuticals

  • Chameleon BioSurfaces

  • Charles River Laboratories

  • Chek Diagnostics

  • Chiesi Farmaceutici

  • Children's Heart Foundation

  • Children's Hospital Boston

  • Children's Hospital of Philadelphia

  • Children's Medical Research Institute

  • Children's Hospital Oakland Research Institute (CHORI)

  • China Grand Pharmaceutical

  • China Medical System

  • Chinese Future Industry Investment Fund

  • Chinese Society of Cardiology

  • Chong Kun Dang

  • Christiana Care Health System

  • Cilag AG

  • C Illies

  • CinCor Pharma

  • Cipher Pharmaceuticals

  • Cipla Medpro

  • Citius Pharmaceuticals

  • Clarity Pharmaceuticals

  • ClearFlow

  • Cleveland Clinic

  • Cleveland HeartLab

  • Clinlogix

  • Coeptis Pharmaceuticals

  • Cofactor Genomics

  • Colibri Heart Valve

  • College of Life Science of Northwest University

  • Columbia University Medical Center

  • Conavi Medical

  • Concordia Healthcare

  • Contatti Medical

  • Cook Medical

  • Coqui RadioPharmaceuticals

  • Cordis

  • CorDynamics

  • CoreRx Pharma

  • Corindus Vascular Robotics

  • CorMatrix Cardiovascular

  • Coroneo

  • CorpMedical

  • Correvio

  • CorVascular

  • Corvia Medical

  • Corvida Medical

  • Corvidia Therapeutics

  • Covalon Technologies

  • Covance

  • Covidien

  • Covis Pharmaceutical

  • Cranford Pharmaceuticals

  • CRISPR Therapeutics

  • Critical Diagnostics

  • Crown Bioscience

  • Cryolife

  • CSL

  • Cure Duchenne

  • CVie

  • CyberHeart

  • Cyclenium Pharma

  • Cynata Therapeutics

  • Cytori Therapeutics

  • CytoSorbents

  • Daewoong Pharmaceutical

  • Daiichi Sankyo

  • DalCor Pharmaceuticals

  • Dalhousie University

  • Dassault Systems

  • DaVinci Biomedical Research Products

  • DecImmune Therapeutics

  • deCODE Genetics

  • Delta

  • Deltex Medical

  • Denovo Biopharma

  • Department of Defense

  • Department of Health and Human Services

  • Dewpoint Therapeutics

  • Diablo Clinical Research

  • diaDexus

  • DiA Imaging Analysis

  • Diaxonhit

  • Dicerna Pharmaceuticals

  • DiNAQOR

  • Dizal Pharmaceutical

  • Dogma Therapeutics

  • Domainex

  • Dorizoe Lifesciences

  • Dr. Reddy's Laboratories

  • Drukier Institute for Children's Health

  • DSM

  • Duke-NUS Graduate Medical School Singapore

  • Duke Clinical Research Institute (DCRI)

  • Duke University

  • Duke University Medical Center

  • Eagle Pharmaceuticals

  • EB Neuro

  • eCardio Diagnostics

  • Eddingpharm

  • Edwards Lifesciences

  • Eiger BioPharmaceuticals

  • Eko

  • ELC Group

  • Electrical Geodesics

  • Elexopharm

  • Eli Lilly

  • Elkhorn Logan Valley Public Health Department

  • Embolitech

  • EmboMedics

  • Emory University

  • Enamine

  • Endo International

  • Endologix

  • Endospan

  • Endotronix

  • Enterprise Partners Venture Capital

  • ENYO Pharma

  • Epsilon

  • Erasmus University Medical Center

  • ERS Genomics

  • ERT

  • Esaote

  • Esperion Therapeutics

  • Espero Pharmaceuticals

  • Eurolab Especialidades Medicinales de Eurofar

  • European Commission

  • European Innovation Council

  • Event Cardio Group

  • Everest Medicines

  • Excelera Network

  • Exelixis

  • Expression Analysis

  • ExScientia

  • FABPulous

  • Feinstein Institute for Medical Research

  • FEops

  • FibriCheck

  • Fine Foods & Pharmaceuticals N.T.M.

  • First Check Diagnostics

  • FitBit

  • Food and Drug Administration (FDA)

  • Foundation for Community Partnerships

  • Frankfurt University Hospital

  • FSD Pharma

  • Fujifilm

  • Fujifilm medical systems

  • Fundacion Progreso y Salud

  • Fu Wai Hospital

  • G3 Pharmaceuticals

  • Galenicum Health

  • Gardia Medical

  • Gatehouse Bio

  • GC Pharma

  • GE Healthcare

  • Geisinger Medical Center

  • Gemphire

  • Genetrix

  • Genomas

  • Genomic Vision

  • Genpharm

  • Genzyme

  • George Clinical

  • George Washington University

  • German Ministry for Education and Research

  • Gestion Univalor

  • Getinge

  • Global Genomics Group

  • Guangdong Provincial People's Hospital

  • Guerbet

  • H2-Pharma

  • Hadasit Medical Research Services and Development

  • Hainan Savy Akers Biosciences

  • Hainan Savy Investment Management

  • Hainan Sihuan Pharmaceutical

  • Hanmi Pharmaceutical

  • Hansen Medical

  • Harbin Gloria Pharmaceuticals

  • Harpoon Medical

  • Harvard Apparatus Regenerative Technology

  • Harvard Pilgrim Health Care

  • Harvard Stem Cell Institute

  • Harvard University

  • Healios K.K.

  • Healthcare Technology Innovation Centre (Chennai)

  • HealthCore

  • Health Sciences Research Institute Germans Trias i Pujol Foundation

  • Healthstream

  • HealthTrust

  • HealthTrust Purchasing Group

  • Heartflow

  • HeartGenetics

  • HeartHero

  • HeartIT

  • Heart Rhythm Society

  • Helix

  • HemCon Medical Technologies

  • HemispheRx Biopharma

  • Hemostasis

  • Hemostemix

  • Henry Ford Health System

  • Henry Schein

  • Hetero Labs

  • Hibernation Therapeutics

  • Hikma Pharmaceuticals

  • HLH BioPharma Vertriebs

  • HLS Therapeutics

  • HoliStick Medical

  • Holmdel Pharmaceuticals

  • Horizon 2020

  • Horizon Discovery

  • Hospices Civils de Lyon

  • Hospital of University of Strasbourg

  • Huami

  • Huapont Pharma

  • Humacyte

  • Human Biosystems

  • iBIO Institute's PROPEL Center

  • Icahn School of Medicine at Mount Sinai

  • iCardiac Technologies

  • Icon

  • Idorsia

  • Ikaria

  • ImagineMIC

  • Impax Laboratories

  • ImpediMed

  • Imperial College London

  • Imricor Medical Systems

  • Independent Medical Coop

  • Indiana Biosciences Research Institute

  • Indiana University

  • Indigo Biosciences

  • InfoBionic

  • InfraReDx

  • inHEART

  • Innovate UK

  • Innovation Network Corporation

  • Innovative Genomics Initiative (IGI)

  • INO Therapeutics

  • iNova Pharmaceuticals

  • Insilico

  • InspireMD

  • InSpire MD

  • Inspyr Therapeutics

  • Insulet

  • Integer Holdings

  • Integrated DNA Technologies

  • Interleukin Genetics

  • Intermountain Healthcare

  • Interrad Medical

  • InterValve

  • INVAP

  • inVentiv Health

  • Invitae

  • Ionis Pharmaceuticals

  • iRhythm Technology

  • ISA Scientific

  • Itamar Medical

  • Jackson Laboratory

  • Jacksonville Pharmaceuticals

  • Jai Capital

  • JanOne

  • Janssen Biotech

  • Janssen Pharmaceuticals

  • Janssen Research & Development

  • Japan Lifeline

  • Jarvik Heart

  • Jasper Capital

  • JNC Medical

  • Johns Hopkins Medicine (JHM)

  • Johns Hopkins University

  • Johnson & Johnson

  • Johnson & Johnson Innovation

  • Juvise Pharmaceuticals

  • Jvion

  • Kaneka

  • Kastle Therapeutics

  • Kennedy Trust For Rheumatology Research

  • Keystone Heart

  • King's College Hospital

  • Kiniksa Pharmaceuticals

  • Kissei Pharmaceutical

  • Kitov

  • Knight Therapeutics

  • KOL Bio Medical Instruments

  • Konica Minolta

  • Korea Animal Medical Science Institute

  • Kowa

  • Kowa Pharmaceuticals America

  • Kuhnil Pharmaceuticals

  • Kyoto University

  • Kyowa Hakko Kirin

  • Laboratory Corporation of America

  • La Jolla Capital

  • La Jolla Pharmaceutical

  • Lannett

  • Lantheus Medical Imaging

  • Lanxess

  • Lee's Pharmaceutical

  • Leiden University

  • Leiters

  • LeMaitre Vascular

  • Leonhardt's Launchpads

  • Leviticus Cardio

  • Lexington Biosciences

  • Life-Assist

  • LifeArc

  • LifeQ

  • LifeWatch Services

  • Ligand Pharmaceuticals

  • LindaCare

  • Linear Health Sciences

  • LivaNova

  • Lokai Medical

  • Lombard Medical Technologies

  • Lonza

  • LORION Enterprises

  • LSU Health Sciences Center

  • Lund University

  • Lupin Limited

  • Luye Pharma Group

  • M2S

  • MagBioSense

  • Magnesium Elektron

  • Magnum Cell Therapies

  • Mallinckrodt Pharmaceuticals

  • Mallory Community Health Center

  • Manna Ministries

  • Maquet Medical Systems

  • Marina Biotech

  • Marizyme

  • Masimo

  • Massachusetts General Hospital

  • Massachusetts Institute of Technology

  • Materialise

  • Matthew Walker Comprehensive Health Center

  • Max-Planck

  • Mayo Clinic

  • MC3 Cardiopulmonary

  • MD Anderson Cancer Center

  • MedAxiom

  • MedCision

  • Medeon Biodesign

  • Medicall Biomedikal

  • Medicure

  • MedImmune

  • Medipal Holdings

  • MediSafe

  • Mediso

  • Medison

  • Medison Pharma

  • Medisun International

  • Meditrade

  • Medline Industries

  • Medovex

  • MedPac Asia Pacific

  • Medtronic

  • Mentice

  • Merck and Co

  • Merck KGaA

  • Merck Serono

  • Merge Healthcare

  • Merus Labs International

  • Mesoblast

  • Mespere LifeSciences

  • Metabasis Therapeutics

  • Metactive

  • Metrion Biosciences

  • Mezzion Pharma

  • Micell Technologies

  • Micro Interventional Devices

  • Micro Medical Solutions

  • MicroPort Scientific

  • MicroPort Sorin CRM (Shanghai)

  • Millar

  • Millipede

  • Ministry of Health (Saudi Arabia)

  • Minnetronix

  • Mitsubishi Tanabe Pharma

  • Mochida Pharmaceutical

  • Moderna Therapeutics

  • Molecular Stethoscope

  • Montreal Heart Institute

  • Morphic Therapeutic

  • Mperia Therapeutics

  • MRI Interventions

  • MSC

  • MSN Laboratories

  • Myant

  • Mylan Laboratories

  • Myocarditis Foundation

  • MyoKardia

  • Myriad RBM

  • myTomorrows

  • N8 Medical

  • Nanion

  • NASA

  • National Cancer Center

  • National Center for Cardiovascular Diseases

  • National Heart

  • Lung and Blood Institute

  • National Institute of Neurological Disorders and Stroke

  • National Institute on Drug Abuse (NIDA)

  • National Institutes of Health

  • National Institutes of Health Center for Regenerative Medicine

  • National Organization for Rare Disorders

  • National Physical Laboratory

  • National Research Council Industrial Research Assistance Program

  • National Science Foundation

  • National University of Singapore

  • Navidea Biopharmaceuticals

  • Ncardia

  • NeoChord

  • Neograft Technologies

  • Neovasc

  • NeuroproteXeon

  • Neurotrope BioScience

  • NeuroVive Pharmaceutical

  • NeuroVive Pharmaceutical Asia

  • New England Research Institutes

  • New York Genome Center (NYGC)

  • NGM Biopharmaceuticals

  • Nido Surgical

  • Nightingale Health

  • Nihon Kohden

  • Nissan Chemical Industries

  • Noden Pharma

  • Nonin Medical

  • North Carolina State University

  • North Georgia Healthcare

  • Northwestern Medicine Bluhm Cardiovascular Institute

  • Northwestern Medicine Developmental Therapeutics Institute

  • Northwestern University

  • Novant Health

  • Novartis

  • Novasep

  • Novation

  • Novella Clinical

  • Novoheart

  • Novo Nordisk

  • Novostia

  • NuCryo Vascular

  • NuMed

  • Numerate

  • Nutricare Costa Rica

  • NuVascular Technologies

  • Nuvo Pharmaceuticals

  • Oberland Capital

  • Ohio State University

  • Olympus

  • OMEICOS Therapeutics

  • Omthera Pharmaceuticals

  • On-X Life Technologies

  • One Drop

  • OnFace

  • Ontario Institute for Cancer Research

  • Opsens

  • OptiBiotix

  • Optina Diagnostics

  • Optum Labs

  • OrbusNeich

  • Orchestra BioMed

  • Orebro University

  • ORIG3N

  • Orphan Canada

  • Ortho-Clinical Diagnostics

  • And Many More Companies!

For more information about this report visit https://www.researchandmarkets.com/r/9ip0pv

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/global-cardiovascular-partnering-deals-reportdirectory-2021-trends-players-and-financials-2014-2021-301373500.html

SOURCE Research and Markets